Literature DB >> 10413323

Elevated neuronal Cdc2-like kinase activity in the Alzheimer disease brain.

K Y Lee1, A W Clark, J L Rosales, K Chapman, T Fung, R N Johnston.   

Abstract

Neurofibrillary tangles (NFT) in Alzheimer's disease (AD) consist largely of hyperphosphorylated tau protein. Many of the phosphorylation sites on tau are serine/threonine-proline sequences, several of which are phosphorylated in vitro by neuronal Cdc2-like kinase (Nclk), a kinase composed of Cdk5 and its activator(s). Thus, tau hyperphosphorylation in AD may result in part from deregulation of Nclk. To test this hypothesis, we examined Nclk activity in prefrontal and cerebellar cortex from 15 postmortem AD and 16 age-matched control subjects, and corrected either for Cdk5 level or for neuronal loss. The ratio of Nclk activity in prefrontal versus cerebellar cortex was then compared. When corrections were made for neuronal loss, the ratios of kinase activity in prefrontal versus cerebellar cortex were significantly higher in AD (6.45+/-0.86) than the controls (3.13+/-0.46; P = 0.003). This finding is consistent with a role for Nclk in the pathogenesis of NFT in AD.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10413323     DOI: 10.1016/s0168-0102(99)00026-7

Source DB:  PubMed          Journal:  Neurosci Res        ISSN: 0168-0102            Impact factor:   3.304


  53 in total

1.  Rapid induction of intraneuronal neurofibrillary tangles in apolipoprotein E-deficient mice.

Authors:  X Bi; A P Yong; J Zhou; C E Ribak; G Lynch
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  CDK5 interacts with Slo and affects its surface expression and kinetics through direct phosphorylation.

Authors:  Jun-Ping Bai; Alexei Surguchev; Powrnima Joshi; Liza Gross; Dhasakumar Navaratnam
Journal:  Am J Physiol Cell Physiol       Date:  2011-11-16       Impact factor: 4.249

3.  Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing.

Authors:  Yi Wen; W Haung Yu; Bryan Maloney; Jason Bailey; Junrong Ma; Isabelle Marié; Thomas Maurin; Lili Wang; Helen Figueroa; Mathieu Herman; Pavan Krishnamurthy; Li Liu; Emmanuel Planel; Lit-Fui Lau; Debomoy K Lahiri; Karen Duff
Journal:  Neuron       Date:  2008-03-13       Impact factor: 17.173

4.  Cyclin-dependent kinase 5 modulates the transcriptional activity of the mineralocorticoid receptor and regulates expression of brain-derived neurotrophic factor.

Authors:  Tomoshige Kino; Howard Jaffe; Niranjana D Amin; Mayukh Chakrabarti; Ya-Li Zheng; George P Chrousos; Harish C Pant
Journal:  Mol Endocrinol       Date:  2010-03-31

5.  A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.

Authors:  Ya-Li Zheng; Sashi Kesavapany; Maneth Gravell; Rebecca S Hamilton; Manfred Schubert; Niranjana Amin; Wayne Albers; Philip Grant; Harish C Pant
Journal:  EMBO J       Date:  2004-12-09       Impact factor: 11.598

Review 6.  Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.

Authors:  Varsha Shukla; Susan Skuntz; Harish C Pant
Journal:  Arch Med Res       Date:  2012-11-07       Impact factor: 2.235

7.  Amino acid sequence conservation of the algesic fragment of myelin basic protein is required for its interaction with CDK5 and function in pain.

Authors:  Andrei V Chernov; Albert G Remacle; Swathi K Hullugundi; Piotr Cieplak; Mila Angert; Jennifer Dolkas; Veronica I Shubayev; Alex Y Strongin
Journal:  FEBS J       Date:  2018-08-27       Impact factor: 5.542

8.  Identification of small molecule inhibitors of beta-amyloid cytotoxicity through a cell-based high-throughput screening platform.

Authors:  K I Seyb; E R Schuman; J Ni; M M Huang; M L Michaelis; M A Glicksman
Journal:  J Biomol Screen       Date:  2008-09-23

9.  Identification of non-muscle myosin heavy chain as a substrate for Cdk5 and tool for drug screening.

Authors:  Anne Jämsä; Karin Agerman; Ann-Cathrin Radesäter; Jan Ottervald; Jonas Malmström; Gösta Hiller; Gang Liu; Mervi Vasänge
Journal:  J Biomed Sci       Date:  2009-06-17       Impact factor: 8.410

10.  No association of CDK5 genetic variants with Alzheimer's disease risk.

Authors:  José Luis Vázquez-Higuera; Ignacio Mateo; Pascual Sánchez-Juan; Eloy Rodríguez-Rodríguez; Jon Infante; José Berciano; Onofre Combarros
Journal:  BMC Med Genet       Date:  2009-07-17       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.